Mehmet Sahin Adiyaman
Overview
Explore the profile of Mehmet Sahin Adiyaman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ekin T, Kis M, Gungoren F, Akhan O, Atici A, Kunak A, et al.
Vaccines (Basel)
. 2023 Apr;
11(4).
PMID: 37112684
Aim: We aimed to evaluate the awareness of pneumococcal vaccination (PCV13, PPSV23) in general cardiology outpatient clinics and impact of physicians' recommendations on vaccination rates. Methods: This was a multicenter,...
2.
Adiyaman M, Canpolat Erkan R, Kaya I, Aba Adiyaman O
Cureus
. 2023 Jan;
14(12):e32748.
PMID: 36686140
Background: Studies on biomarkers in the diagnosis of myocardial infarction are ongoing. Adropin is a biomarker that has been studied and has been shown to have different effects. This study...
3.
Adiyaman M, Aba Adiyaman O, Dagli A, Karahan M, Dagli M
Rev Port Cardiol
. 2022 Sep;
41(2):99-105.
PMID: 36062712
Introduction: Doxorubicin (DOX) is an anthracycline cytotoxic chemotherapeutic drug that is commonly used in cancer treatment. A major side effect limiting the clinical use of DOX is cardiotoxicity due to...
4.
Akyuz A, Isik F, Aslan B, Cap M, Kaya I, Atli O, et al.
Clin Exp Hypertens
. 2021 May;
43(7):587-596.
PMID: 33955313
Introduction: We have aimed to investigate the relationship between use of angiotensin-converting-enzyme inhibitor (ACEI) or angiotensin-receptor-blocker (ARB) drugs and acute hypoxemic respiratory failure (AHRF) and in-hospital mortality in hypertensive Covid-19...
5.
Cap M, Bilge O, Isik F, Burak C, Karagoz A, Inci U, et al.
J Electrocardiol
. 2020 Nov;
63:115-119.
PMID: 33181454
Background: The effect of favipiravir on the QTc interval during the treatment of Coronavirus Disease 2019 (COVID-19) patients is unclear. Thus, the current study objective was to evaluate any change...
6.
Adiyaman M, Aba Adiyaman O, Dagli A, Karahan M, Kaya I, Dagli M
Herz
. 2020 Jan;
46(Suppl 1):103-108.
PMID: 31970462
Background: Doxorubicin (DX) is used for the treatment of many types of cancer; however, a side effect of this agent is cardiotoxicity, which may lead to cardiomyopathy or cardiac failure....
7.
Karahan Z, Altintas B, Ugurlu M, Kaya I, Ucaman B, Ulug A, et al.
JRSM Cardiovasc Dis
. 2016 Aug;
5:2048004016657475.
PMID: 27570619
Background: It is known that QRS duration is related to prognosis in acute myocardial infarction. The relation between QRS duration and coronary collateral circulation is uncertain. In the present study,...
8.
Karahan Z, Ugurlu M, Ucaman B, Ulug A, Kaya I, Cevik K, et al.
Open Cardiovasc Med J
. 2016 Jun;
10:117-21.
PMID: 27347229
Background: Angiotensin converting enzyme (ACE) gene polymorphism is associated with high renin-angiotensin system causing myocardial fibrosis and ventricular repolarization abnormality. Based on these findings, this study was designed to determine...
9.
Altas Y, Kurtoglu E, Yaylak B, Baysal E, Ucaman B, Ugurlu H, et al.
Ther Clin Risk Manag
. 2015 Aug;
11:1187-91.
PMID: 26316763
Aim: The pathophysiology of slow coronary flow (SCF) involves atherosclerosis, small vessel dysfunction, platelet function disorders, and inflammation. It has been known that eosinophils also play a significant role in...
10.
Sevuk U, Altindag R, Baysal E, Yaylak B, Adiyaman M, Akkaya S, et al.
Perfusion
. 2015 Jul;
31(3):232-9.
PMID: 26205807
Unlabelled: Excessive haemodilution and the resulting anaemia during CPB is accompanied by a decrease in the total arterial oxygen content, which may impair tissue oxygen delivery. Hyperoxic ventilation has been...